42 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Yield10 Bioscience Inc YTEN shares jumped 183.59 percent to close at $5.53 on Monday after the company reported granting of research license to Monsanto for evaluation of 2 novel yield traits in soybean.
  • ARGENX SE/S ADR ARGX shares climbed 78.88 percent to close at $54.47 after the company reported positive topline results from Phase 2 proof-of-concept trial of ARGX-113 in generalized myasthenia gravis.
  • Seven Stars Cloud Group Inc SSC shares surged 47.35 percent to close at $3.61 on Monday.
  • Riot Blockchain Inc RIOT shares climbed 45.52 percent to close at $23.08 on Monday after gaining 8.63 percent on Friday.
  • Marathon Patent Group Inc MARA shares rose 42.86 percent to close at $6.30 on Monday after declining 3.71 percent on Friday.
  • Sunesis Pharmaceuticals, Inc. SNSS jumped 38.71 percent to close at $3.44. Wells Fargo upgraded Sunesis Pharmaceuticals from Market Perform to Outperform.
  • U.S. Global Investors, Inc. GROW shares jumped 35.02 percent to close at $5.33.
  • Net Element Inc NETE shares surged 34.99 percent to close at $5.44 on Monday.
  • Arcimoto Inc FUV shares rose 33.83 percent to close at $3.60.
  • Famous Dave's of America, Inc. DAVE shares climbed 32.08 percent to close at $7.00.
  • Xunlei Ltd XNET shares rose 29.38 percent to close at $15.50 on Monday.
  • Blueprint Medicines Corp BPMC gained 22.91 percent to close at $88.32 on Monday after the company announced new data from ongoing Phase 1 clinical trial of Avapritinib.
  • Overstock.com Inc OSTK climbed 22.02 percent to close at $55.00 following 13G filing from Morgan Stanley late Friday showing increased stake from 130,000 shares to 2.87 million shares.
  • Clearside BioMedical, Inc. CLSD shares jumped 19.69 percent to close at $7.05.
  • bluebird bio Inc BLUE shares rose 17.91 percent to close at $201.80 after the company announced updated clinical results from ongoing Phase 1 multicenter study of LentiGlobin gene therapy in severe sickle cell disease at the ASH2017.
  • Chicken Soup for The Soul Entrtnmnt Inc CSSE shares rose 17.04 percent to close at $9.48.
  • Social Reality Inc SRAX shares jumped 16.96 percent to close at $6.00. Social Reality Inc announced late Friday a litigation settlement with tronc Inc and Tribune Content Agency over an alleged breach of contract and deceptive business practices. Social Reality also filed for 4,746,820 offering from selling shareholders.
  • Consol Energy Inc CEIX shares rose 16.28 percent to close at $29.50 on Monday.
  • Intersect ENT Inc XENT shares gained 14.51 percent to close at $32.75 as the company reported the FDA approval of SINUVA Sinus Implant as a treatment option for recurrent nasal polyps.
  • Shineco Inc TYHT shares gained 12.77 percent to close at $2.9546 after the company disclosed a Share Exchange and Acquisition deal with Western Xinjiang Tiansheng Agricultural Development Co.
  • SunPower Corporation SPWR rose 10.67 percent to close at $9.23. Baird upgraded SunPower from Neutral to Outperform.
  • CHF Solutions Inc CHFS shares rose 10.59 percent to close at $3.80 on Monday after climbing 11.00 percent on Friday.
  • Catalyst Biosciences Inc CBIO rose 10.21 percent to close at $8.31 as the company announced promising interim Phase 1/2 CB 2679D/ISU304 results at the ASH2017.
  • Helios and Matheson Analytics Inc HMNY rose 8.05 percent to close at $9.13 following news of a new marketing and performance-based sales deal with a movie distributor.
  • Trade Desk Inc TTD gained 6.74 percent to close at $48.30. SunTrust Robinson Humphrey upgraded Trade Desk from Hold to Buy.


Losers

  • Spark Therapeutics Inc ONCE shares tumbled 34.97 percent to close at $47.72 on Monday on volatile factor VIII activity data in hemophilia A gene therapy.
  • Syros Pharmaceuticals Inc SYRS dipped 31.69 percent to close at $8.45 following presentation at the ASH 2017 on Phase 2 trial of SY-1425 in genomically defined AML and MDS patients.
  • Technical Communications Corporation TCCO shares dropped 21.26 percent to close at $5.00 on Monday. Technical Communications reported a Q4 loss of $0.28 per share on revenue of $1.125 million.
  • Wins Finance Holdings Inc WINS shares declined 18.66 percent to close at $47.02.
  • Verastem Inc VSTM shares fell 16.86 percent to close at $3.60 after the company announced clinical data from the pivotal Phase 3 DUO study.
  • Athenex Inc ATNX shares dropped 16.3 percent to close at $13.37. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.
  • Long Island Iced Tea Corp LTEA shares fell 15.59 percent to close at $1.70.
  • bebe stores, inc. BEBE shares dipped 15.08 percent to close at $4.73. Bebe stores announced intention to voluntarily delist from the NASDAQ and begin trading on OTCQB.
  • Juno Therapeutics Inc JUNO declined 14.34 percent to close at $50.24. Juno Therapeutics and Celgene released additional data from the TRANSCEND trial of JCAR017 in patients with relapsed or refractory aggressive B-cell non-hodgkin lymphoma.
  • Co-Diagnostics Inc CODX shares fell 13.64 percent to close at $3.80.
  • Trillium Therapeutics Inc TRIL shares dropped 13.33 percent to close at $9.75 on Monday.
  • Arsanis Inc ASNS shares declined 12.53 percent to close at $12.22 on Monday.
  • Novan Inc NOVN shares slipped 11.16 percent to close at $4.30.
  • Ovid Therapeutics Inc OVID shares dropped 10.99 percent to close at $10.45.
  • Hornbeck Offshore Services, Inc. HOS shares slipped 10.86 percent to close at $2.79.
  • Anavex Life Sciences Corp AVXL shares fell 10.57 percent to close at $3.30. Anavex Life Sciences reported FY17 loss of $0.33 per share, versus a year-ago loss of $0.42 per share.
  • Seattle Genetics, Inc. SGEN shares declined 6.74 percent to close at $ 55.265. Seattle Genetics highlighted five-year survival results from Phase 1 trial of ADCETRIS in frontline mature T-cell lymphoma at the ASH 2017.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversHealth CareMovers From YesterdayPharmaceuticalsTop GainersYesterday's GainersYesterday's Losers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...